• Geneticin (G418 Sulfate): Redefining Selection and Antiviral

  2026-06-23

  Explore the mechanistic foundations and translational impact of Geneticin (G-418 Sulfate), an aminoglycoside antibiotic central to genetic engineering and antiviral research. This article frames current challenges in cell line development and virus inhibition, integrates insights from recent mechanistic studies, and offers strategic guidance for leveraging APExBIO's ultra-pure Geneticin in advanced translational workflows.

• WIP1/PPM1D Inhibition Drives Pyroptosis via p38 MAPK in AKI

  2026-06-23

  This study uncovers how pharmacological inhibition of WIP1/PPM1D augments renal tubular pyroptosis during sepsis-associated acute kidney injury (AKI) through enhanced p38 MAPK activation. The findings illuminate a critical regulatory axis in inflammatory kidney injury and provide a mechanistic basis for using PPM1D inhibitors to dissect pyroptosis in translational research.

• SB743921: Precision Kinesin Spindle Protein Inhibitor Workfl

  2026-06-22

  SB743921, a highly selective kinesin spindle protein inhibitor, enables robust cell cycle arrest and apoptosis studies in diverse cancer models. This article demystifies hands-on workflows, troubleshooting strategies, and the latest in vitro assay innovations that maximize reproducibility and data quality with SB743921.

• Human iPSC Sensory Neuron Model Validated for HSV-1 Latency

  2026-06-22

  This study establishes and validates a robust protocol for differentiating human inducible pluripotent stem cells into sensory neurons, enabling reproducible modeling of herpes simplex virus 1 (HSV-1) latency and reactivation in vitro. The findings provide a scalable human-based system to dissect neuron-intrinsic mechanisms of HSV-1 persistence and inform future therapeutic strategies against latent herpesvirus infection.

• ML216: BLM Helicase Inhibitor for Precision DNA Repair Resea

  2026-06-21

  ML216 enables selective, submicromolar inhibition of BLM helicase, unlocking targeted studies of DNA repair vulnerabilities and synthetic lethality in cancer models. This article delivers actionable workflows, troubleshooting solutions, and translational insights for maximizing ML216's impact in preclinical oncology.

• Medroxyprogesterone Acetate: Biological Roles and Protocol B

  2026-06-20

  Medroxyprogesterone acetate (MPA) is a synthetic steroidal progestin vital for hormone replacement therapy research, endometriosis models, and renal epithelial studies. It acts via progesterone and glucocorticoid receptors, with unique effects on gene expression and neurobiology. MPA’s protocol parameters are well-characterized for reproducible laboratory use.

• ATM-Targeted TACE Silencing with ATS-9R for Obesity-Related

  2026-06-19

  Yong et al. developed a non-viral gene delivery peptide, ATS-9R, enabling selective silencing of TACE in visceral adipose tissue macrophages to alleviate inflammation and insulin resistance in obese mice. This targeted approach advances metabolic disease research by demonstrating effective, tissue-specific gene silencing in vivo.

• G418 Sulfate (Geneticin): Selection, Antiviral, and Workflow

  2026-06-19

  Geneticin (G418 Sulfate) excels as both a gold-standard selection antibiotic and a versatile antiviral tool, enabling precise genetic engineering and Dengue virus research. This in-depth guide bridges molecular principles, protocol optimization, and troubleshooting insights to help researchers unlock the full experimental potential of APExBIO’s ultra-pure G-418.

• Dietary Arachidonic Acid Enhances Humoral Immunity Post-Vacc

  2026-06-18

  A recent study demonstrates that dietary supplementation with arachidonic acid (ARA) significantly accelerates and amplifies humoral immune responses to rabies vaccination in both mice and humans. This work uncovers a metabolic pathway by which ARA-derived prostaglandins modulate B cell activation, offering a translational strategy for improving vaccine efficacy through targeted lipid interventions.

• Calpain Inhibitor I, ALLN: Technical Use in Apoptosis & Inju

  2026-06-18

  Calpain Inhibitor I, ALLN (A2602) offers precise inhibition of calpains and cathepsins, supporting mechanistic research in apoptosis assays and ischemia-reperfusion injury models. This compound is not suitable for diagnostic or therapeutic use and requires careful handling and workflow control to preserve activity and reproducibility.

• Clathrin-Mediated Entry of Spiroplasma eriocheiris in Drosop

  2026-06-17

  This study reveals that Spiroplasma eriocheiris invades Drosophila Schneider 2 cells through clathrin-mediated endocytosis and macropinocytosis, bypassing caveola-dependent pathways. These mechanistic insights refine infection modeling in invertebrate systems and inform future research on host-pathogen interactions.

• AMG 487 as a Precision Modulator of CXCR3 in Macrophage Pola

  2026-06-17

  Explore how AMG 487, a potent CXCR3 antagonist, enables precise, state-dependent modulation of macrophage polarization via autophagy and chemokine signaling. This article delivers advanced insights distinct from existing workflows, with a focus on translational assay design.

• SmD2 Acetylation Drives PARP Inhibitor Sensitivity in HCC

  2026-06-16

  This study uncovers how acetylation-dependent regulation of the spliceosome core protein SmD2 modulates DNA repair and sensitizes hepatocellular carcinoma (HCC) cells to PARP inhibition. The findings reveal a mechanistic link between spliceosome regulation, alternative splicing, and therapeutic vulnerability, suggesting new strategies for targeting DNA repair in BRCA1/2-proficient HCC.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-16

  Anlotinib hydrochloride empowers researchers with high-fidelity inhibition of angiogenesis and tumor cell proliferation, outperforming legacy TKIs in both selectivity and safety. Explore advanced experimental workflows, actionable troubleshooting tips, and real-world insights that unlock translational cancer research potential.

• AMG 487: Optimizing CXCR3 Antagonist Workflows in Macrophage

  2026-06-15

  AMG 487, a potent CXCR3 antagonist from APExBIO, enables precise manipulation of macrophage polarization and autophagy states in both inflammatory and non-inflammatory models. This article provides actionable workflows, troubleshooting insights, and data-backed protocol parameters to maximize the value of AMG 487 in chemokine signaling and inflammation research.

15856 records 1/1058 page Next 12345 下5页 Last page